NEW YORK, Jan. 21, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to neurodegeneration and apoptosis, and Brewer Sports International (BSI), a multi-faceted global sports advisory firm, are pleased to provide an update surrounding the Amarantus #C4CT Summit hosted by Brewer Sports International, powered by MDM Worldwide, to be held on Wednesday, January 29th in the Trusteeship Council at the United Nations in New York City, NY during Super Bowl Week.
The conference will unite industry experts, leading scientists, neurologists and international business leaders with current and former professional athletes in effort to create consensus on the path forward for scientific research and commercial development.
LIMITED REGISTRATION OPEN AND SPONSORSHIP OPPORTUNITIES STILL AVAILABLE
To register or for additional information, please visit www.c4ctsummit.com. Space is limited and pre-registration is required. For further information surrounding sponsorship opportunities, please contact Danielle Berman at firstname.lastname@example.org. Students interested in attending the conference are able to register with limited access to the conference for free and must show a valid student ID upon check in.
Below is a list of prestigious participants from the sports field, including current and retired professional athletes, broadcasters and other key stakeholders for the #C4CT Concussion Awareness Summit. Full agenda including all scheduled presenters is included following the release.
"As a former NFL player, I am passionate about making strides to improve the health and safety of my fellow professional athletes, both former and current," said Jack Brewer, CEO of Brewer Sports International. "Instead of pointing fingers, we have put together a world class panel of researchers to discuss TBI-induced Neurodegeneration and CTE with those directly affected by and equally passionate about the cause as we strive to enhance awareness and work to find viable treatments."
The #C4CT Summit is the opening of the five-day Brewer Sports International Super Bowl XLVIII Exclusive Events series, which includes The Jack Brewer Foundation (JBF Worldwide) Global Ambassadors Sport for Development Summit, Super Bowl Blue Carpet Event and the 6th Annual JBF Worldwide Super Bowl Watch Event at the Grand Havana Room.
#C4CT Concussion Awareness Summit // Working Agenda
Wednesday, January 29, 2014 // United Nations // 8:00am - 6:00pm
Emceed by NFL Network's Andrea Kremer
*All times and presenters subject to change
7:00 - 8:00am: Registration & Continental Breakfast
8:00 - 8:30am: Welcome & Opening Keynote Address
8:30 – 10:00am: Long Term Consequences of Repetitive Brain Trauma: CTE and Neurodegeneration
10:00 - 10:15am: CTE and Neurodegeneration Panel
10:15 - 11:00am: Diagnostics and Standard of Care
11:00 - 11:15am: Diagnostics and Standard Care Panel: Moderated by Dr. Russell Warren, NY Giants Team Physician
11:20 - 12:10pm: World Impact of TBI
12:15 – 2:00pm: Lunch
1:15-1:45pm: Keynote Address
2:00 - 2:30pm: Emerging Diagnostic Tools and Potential Therapies Under Investigation
2:30 - 3:00pm: Public Policy Panel
3:00 - 3:15pm: Personal Story
3:15 - 3:30pm: Concussions in College Sports
3:30 - 3:45pm: NFL Settlement
4:00 - 4:45pm: Future of Contact Sports Panel
Agents / Service Providers / Investors
Professional Sports and NCAA
Youth and High School Sports
4:45pm: Leigh Steinberg, CEO of Steinberg Sports and Entertainment
5:00pm: Athlete Introduction
5:15 - 6:00pm: Current and Former Professional Athlete Stories and Perspectives Panel
Moderated by Carl Eller, NFL Hall of Famer and President and Chairman of the Board of NFL Retired Players Association
6:00pm: #C4CT Reception
About Amarantus BioScience Holdings, Inc.
Amarantus is a development-stage biotechnology company focused on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, Alzheimer's disease, Traumatic Brain Injury, and other human diseases. The Company has an exclusive worldwide license to the Lymphocyte Proliferation test ("LymPro Test®") for Alzheimer's disease and owns the intellectual property rights to the therapeutic protein Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for various protein folding-related medical conditions. The Company also is a Founding Member of the Coalition for Concussion Treatment (#C4CT), in collaboration with Brewer Sports International raising awareness of new products in development for concussions and traumatic brain injury. The Company also owns intellectual property for the diagnosis of Parkinson's disease ("NuroPro") and the discovery of neurotrophic factors ("PhenoGuard"). Amarantus operations are located at Janssen Labs @QB3 in San Francisco, CA. For further information please visit www.Amarantus.com, or connect with the Company on Facebook, LinkedIn, Twitter and Google+.
About Brewer Sports International
Brewer Sports International (BSI) is a multi-faceted sports advisory firm within The Brewer Group Companies with a focus on the business of sports, wellness and media for professional athletes, sports agencies, public and private corporations and various partners including international organizations, governments and NGOs. Based in Minneapolis, with offices in New York, Dallas, Miami, Beijing and Malawi, BSI was founded by Jack Brewer, a five-year National Football League (NFL) veteran and former team captain on three NFL teams. Additionally, BSI has created a unique financial services platform that is offered to professional athletes and sports agencies, as well as high net worth individuals and businesses touching professional sports. BSI takes pride in enabling its clients to capitalize on the endless opportunities presented through sport. For more information, please visit www.brewersports.com or follow them on Facebook, Twitter and LinkedIn.
About MDM Worldwide
MDM Worldwide Solutions, Inc. is a digital communications agency that develops and manages online engagement strategies to connect companies with their stakeholders. MDM specializes in working with clients in the technology, healthcare and life sciences spaces. MDM's vast industry knowledge, proprietary methodology, proven track record and experienced leadership team enables them to create and customize targeted digital marketing campaigns to fulfill all of their clients' objectives. For more information, please visit mdmworldwide.com or find them on Facebook, Twitter, Google+ and LinkedIn.
Amarantus Bioscience Holdings, Inc.: Russell Miller, Director of Investor Relations 408.737.2734 x 101 Brewer Sports International: Danielle Berman, Director of Business Development and Media (443) 841-4667
Amarantus BioScience Holdings, Inc.
San Francisco, California, UNITED STATES
Day's Range: 0.10-0.19
Previous Close: 0.18
Market Cap: 80.45M
Day's Volume: 45,496,228
Amarantus BioScience Holdings, Inc. Logo